Position in IONS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$74,301,311
+$12,386,603 QoQ
Shares Held
937,083
+13.6% QoQ
Ownership
0.564%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#33
of 510 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GROUPAMA ASSET MANAGMENT holds $277,486,304 across 10 Biotechnology names. IONS ranks #2 (26.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
188,156 | $93,462,729 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
This page
|
937,083 | $74,301,311 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
77,940 | $48,598,707 | |
| 4 | BNTX |
BioNTech SE
|
184,775 | $17,193,313 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
30,941 | $16,613,769 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
34,252 | $10,310,879 | |
| 7 | INCY |
Incyte Corp
|
86,423 | $9,796,911 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
229,939 | $5,914,031 |
All Filings in IONS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,301,311 | 937,083 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $61,914,708 | 824,540 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $60,668,588 | 766,889 | Shares | Sole | 2026-02-27 | |
| 2025-09-30 | $36,751,451 | 561,777 | Shares | Sole | 2025-12-01 | |
| 2025-09-30 | $685,275 | 500,000 | Principal | Sole | 2025-12-01 | |
| 2025-06-30 | $527,382 | 500,000 | Principal | Sole | 2025-08-13 | |
| 2025-06-30 | $26,114,411 | 660,957 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $17,173,095 | 569,211 | Shares | Sole | 2025-05-14 | |
| 2025-03-31 | $494,326 | 500,000 | Principal | Sole | 2025-05-14 | |
| 2024-12-31 | $494,514 | 500,000 | Principal | Sole | 2025-02-12 | |
| 2024-12-31 | $18,080,997 | 517,191 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $16,667,363 | 416,060 | Shares | Sole | 2024-11-15 | |
| 2024-09-30 | $418,605 | 500,000 | Principal | Sole | 2024-11-15 | |
| 2024-06-30 | $18,109,656 | 379,976 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,178,577 | 257,868 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $18,062,451 | 357,036 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||